Etanercept has only minimal cost effect in juvenile RA

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.468, 2004-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Etanercept has only minimal cost effect in juvenile RA

Inpharma, Vol. 1, Iss. 1469, 2005-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Etanercept: new era of treatment for juvenile RA

Inpharma, Vol. 1, Iss. 1230, 2000-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Etanercept considered cost effective vs DMARDs in RA

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 446, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

First-year cost savings may be greater with etanercept in RA

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 482, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

First-year cost savings may be greater with etanercept in RA

Inpharma, Vol. 1, Iss. 1498, 2005-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite